Prospect: information for the user
ZARATOR 10mg chewable tablets
atorvastatina
Read this prospect carefully before starting to take this medication,because it contains important information for you.
1.What is Zarator and for what it is used
2.What you need to know before starting to take Zarator
3.How to take Zarator
4.Possible adverse effects
5.Storage of Zarator
6.Contents of the package and additional information
Zarator belongs to a group of medications known as statins, which are medications that regulate lipids (fats).
Zarator is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes alone have failed.If you have a high risk of heart disease,Zaratormay also be used to reduce this risk even if your cholesterol levels are normal.During treatment, a standard low-cholesterol diet must be followed.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Zarator.
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with Zarator to predict the risk of adverse effects related to muscle. It is known that the risk of adverse effects related to muscle (e.g., rhabdomyolysis) increases when certain medications are taken at the same time (see section 2 “Zarator use with other medications”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While taking this medication, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and lipid levels, obesity, and high blood pressure.
Other medications and Zarator
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. There are some medications that may affect the proper functioning of Zarator or the effects of these medications may be modified by Zarator. This type of interaction may reduce the effect of one or both medications. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4:
Taking Zarator with food, drinks, and alcohol
See section 3 for instructions on how to take Zarator. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice may alter the effects of Zarator.
Alcohol
Avoid drinking large amounts of alcohol while taking this medication. See details in section 2 “Warnings and precautions”.
Pregnancy, breastfeeding, and fertility
Do not take Zarator if you are pregnant, think you may be pregnant, or intend to become pregnant.
Do not take Zarator if you are fertile and do not use adequate contraceptive measures.
Do not take Zarator if you are breastfeeding your child.
Zarator has not been proven safe during pregnancy and breastfeeding.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
This medication usually does not affect your ability to drive or operate machinery. However, do not drive if this medication affects your ability to drive. Do not operate tools or machinery if this medication affects your ability to do so.
Zarator contains aspartame
This medication contains 1.25 mg of aspartame in each chewable tablet.
Aspartame contains a source of phenylalanine that may be harmful in cases of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Zarator contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per chewable tablet, which is essentially “sodium-free”.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Zarator.
The usual initial dose of Zarator is 10 mg once a day in adults and children aged 10 years and above. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of Zarator is 80 mg once a day.
Zarator tablets can be chewed or taken whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Follow exactly the administration instructions for this medication indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the duration of treatment with Zarator
Ask your doctor if you think the effect of Zarator is too strong or too weak.
If you take more Zarator than you should
If you accidentally take too many chewable tablets of Zarator (more than your usual daily dose), consult your doctor or the nearest hospital or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken. Bring the remaining tablets, the packaging, and the complete box so that the hospital staff can easily identify the medication you have taken.
If you forget to take Zarator
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Zarator
If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following side effects or severe symptoms, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency department.
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Other possible side effects with Zarator
Frequent: may affect up to 1 in 10 people
Occasional: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data:
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthis medicationout of sight and reachof children.
Do not usethis medicationafter the expiration datethat appears on the blister and on the packaging after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need.This will help protect the environment.
Each tablet contains 10 mg of atorvastatina (as atorvastatina calcium trihydrate).
Appearance of the product and contents of the packaging
Zarator 10 mg chewable tablets are white or off-white, with a pink to purple speckling, round in shape. They are marked with 10 on one side and LCT on the other.
Zarator 10 mg chewable tablets are presented in packaging with blisters containing 30 chewable tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
You can request more information about this medication by contacting the local representative of the holder of the marketing authorization:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 Madrid
Spain
Last review date of this leaflet: October 2024
The detailed information about this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.